Home › Compare › BDYS vs EPRT

BDYS vs EPRT: Dividend Comparison 2026

BDYS yields 1666666.67% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BDYS wins by $7.881388007847456e+38M in total portfolio value
10 years
BDYS
BDYS
● Live price
1666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.881388007847456e+38M
Annual income
$788,045,788,464,202,500,000,000,000,000,000,000,000,000,000.00
Full BDYS calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — BDYS vs EPRT

📍 BDYS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBDYSEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BDYS + EPRT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BDYS pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BDYS
Annual income on $10K today (after 15% tax)
$141,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$669,838,920,194,572,100,000,000,000,000,000,000,000,000,000.00/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, BDYS beats the other by $669,838,920,194,572,100,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BDYS + EPRT for your $10,000?

BDYS: 50%EPRT: 50%
100% EPRT50/50100% BDYS
Portfolio after 10yr
$3.940694003923728e+38M
Annual income
$394,022,894,232,101,200,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

BDYS
No analyst data
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BDYS buys
0
EPRT buys
0
No recent congressional trades found for BDYS or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBDYSEPRT
Forward yield1666666.67% ✓3.92%
Annual dividend / share$2.00 ✓$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29% ✓
Portfolio after 10y$7.881388007847456e+38M$63.4K ✓
Annual income after 10y$788,045,788,464,202,500,000,000,000,000,000,000,000,000,000.00 ✓$12,840.73
Total dividends collected$7.881327152392866e+38M$37.9K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BDYS vs EPRT ($10,000, DRIP)

YearBDYS PortfolioBDYS Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$166,677,367$166,666,666.67$11,205$505.18+$166.67M → BDYS
2$2,596,399,009,372$2,596,220,664,589.82$12,672$682.46+$2596399.00M → BDYS
3$37,799,368,960,870,740$37,796,590,813,930,710.00$14,490$930.48+$37799368960.86M → BDYS
4$514,299,522,501,000,700,000$514,259,077,176,212,500,000.00$16,786$1,282.69+$514299522501000.69M → BDYS
5$6,539,827,688,394,773,000,000,000$6,539,277,387,905,697,000,000,000.00$19,753$1,791.56+$6539827688394772480.00M → BDYS
6$77,720,443,582,794,890,000,000,000,000$77,713,445,967,168,310,000,000,000,000.00$23,677$2,541.64+$7.772044358279489e+22M → BDYS
7$863,223,381,090,722,600,000,000,000,000,000$863,140,220,216,089,000,000,000,000,000,000.00$29,008$3,672.99+$8.632233810907226e+26M → BDYS
8$8,960,459,278,400,958,000,000,000,000,000,000,000$8,959,535,629,383,190,000,000,000,000,000,000,000.00$36,463$5,425.08+$8.960459278400959e+30M → BDYS
9$86,927,402,376,655,070,000,000,000,000,000,000,000,000$86,917,814,685,227,190,000,000,000,000,000,000,000,000.00$47,238$8,221.57+$8.692740237665508e+34M → BDYS
10$788,138,800,784,745,600,000,000,000,000,000,000,000,000,000$788,045,788,464,202,500,000,000,000,000,000,000,000,000,000.00$63,385$12,840.73+$7.881388007847456e+38M → BDYS

BDYS vs EPRT: Complete Analysis 2026

BDYS — Stock

BodyScan Corp. offers medical imaging services that include GE-Imatron Electron Beam Tomography (EBT) scanning for coronary artery disease (CAD), lung diseases, tumors, and stones detection. The company is based in Irvine, California.

Full BDYS Calculator →

EPRT — REIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this BDYS vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BDYS vs SCHDBDYS vs JEPIBDYS vs OBDYS vs KOBDYS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.